Rossari Biotech Ltd Q3 FY2024 consolidated PAT increases to Rs. 34.39 crores

Rossari Biotech Limited has reported Consolidated financial results for the period ended December 31, 2023.

Financial Results (Q3 FY2024) - QoQ Comparison

The company has reported total income of Rs. 467.271 crores during the period ended December 31, 2023 as compared to Rs. 484.832 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs. 34.390 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 32.948 crores for the period ended September 30, 2023.

The company has reported EPS of Rs. 6.21 for the period ended December 31, 2023 as compared to Rs. 5.95 for the period ended September 30, 2023.

Financials	Q3 FY2024	Q2 FY2024	% Change
Total Income	₹ 467.271 crs	₹484.832 crs	-3.62%
Net Profit	₹34.390 crs	₹32.948 crs	4.38%
EPS	₹6.21	₹5.95	4.37%

Financial Results (Q3 FY2024) - YoY Comparison

The company has reported total income of Rs. 467.271 crores during the period ended December 31, 2023 as compared to Rs.390.383 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.34.390 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.25.681 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.6.21 for the period ended December 31, 2023 as compared to Rs.4.63 for the period ended December 31, 2022.

Financials	Q3 FY2024	Q3 FY2023	% Change
Total Income	₹ 467.271 crs	₹390.383 crs	19.70%
Net Profit	₹34.390 crs	₹25.681 crs	33.91%
EPS	₹6.21	₹4.63	34.13%

Financial Results (9 Months Ended FY2024) - YoY Comparison

The company has reported total income of Rs.1364.899 crores during the 9 Months period ended December 31, 2023 as compared to Rs.1252.093 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.96.557 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.78.278 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.17.45 for the 9 Months period ended December 31, 2023 as compared to Rs.14.14 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended FY2024	9 Months Ended FY2023	% Change
Total Income	₹1364.899 crs	₹1252.093 crs	9.01%
Net Profit	₹96.557 crs	₹78.278 crs	23.35%
EPS	₹17.45	₹14.14	23.41%

Asset Quality:

Asset Quality	Q3 FY2024	Q2 FY2024	Q3 FY2023
Gross NPA	₹ crs	₹ crs	₹ crs
Gross NPA %	%	%	%
Net NPA	₹ crs	₹ crs	₹ crs
Net NPA %	%	%	%

Gross NPA was at ₹ crs in Q3 FY2024 against ₹ crs in Q3 FY2023. The same was at ₹ crs in Q2 FY2024.

Net NPA was at ₹ crs in Q3 FY2024 against ₹ crs in Q3 FY2023. The same was at ₹ crs in Q2 FY2024.

GNPA was at % of Gross advances as on December 31, 2023 as compared to % as on December 31, 2022 and % as of September 30, 2023.

Net NPA was at % of Gross advances as on December 31, 2023 as compared to % as on December 31, 2022 and % as of September 30, 2023.

Ratios	Q3 FY2024	Q2 FY2024	Q3 FY2023
RoA %	%	%	%
CAR (BASEL III) %	%	%	%

Return on Average Assets (RoA) is at % for Q3 FY2024 against % in Q2 FY2024 and % in Q3 FY2023.

In Q3 FY2024, Bank's total Capital Adequacy Ratio (CAR) was at %, as compared to % in Q2 FY2024 and % in Q3 FY2023.

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 819.00 as compared to the previous close of Rs. 787.15. The total number of shares traded during the day was 18330 in over 1932 trades.

The stock hit an intraday high of Rs. 825.00 and intraday low of 791.35. The net turnover during the day was Rs. 14827401.00.

Source : Equity Bulls

Keywords

RossariBiotech Q3FY24 9MFY24 ResultUpdate